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Development of improved drug and gene delivery systems directly into the lungs is
highly desirable given the important burden of respiratory diseases. We aimed to
evaluate the safety and efficacy of liposomes composed of photopolymerized lipids
[1,2-bis-(tricosa-10,12-diynoyl)-sn-glycero-3-phosphocholine] associated with amino
acids as vectors for gene delivery into the lungs of healthy animals. Lipopolymer vesicles,
in particular, are more stable than other types of liposomes. In this study, lipopolymers
were associated with L-arginine, L-tryptophan, or L-cysteine. We hypothesized that the
addition of these amino acids would enhance the efficacy of gene delivery to the lungs by
the lipopolymers. L-Arginine showed the highest association efficiency due to its positive
charge and better surface interactions. None of the formulations caused inflammation or
altered lung mechanics, suggesting that these lipopolymers can be safely administered
as aerosols. All formulations were able to induce eGFP mRNA expression in lung tissue,
but the addition of amino acids reduced delivery efficacy when compared with the simple
lipopolymer particle. These results indicate that this system could be further explored for
gene or drug delivery targeting lung diseases.
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INTRODUCTION
Respiratory illnesses are a major health issue worldwide. Lung infections are the most important
single contributor to the overall burden of disease in the world, and more than one billion people
have chronic respiratory conditions (Zar and Ferkol, 2014). Despite easy access to respiratory tract,
the local delivery of drugs to the lung tissue is complicated because of the unique architecture of
the respiratory system and its natural defense mechanisms (Griesenbach and Alton, 2009). New
therapeutic strategies have been proposed to overcome the limitations of conventional systems,
including a large variety of nanoparticles.
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Liposomes are small biocompatible vesicles with the ability
to protect cargo from degradation, favoring controlled delivery.
Their similarity to lung surfactant—both are enriched in
phospholipids—makes them good candidates for lung delivery
strategies (Cipolla et al., 2014). They also have the advantages
of low cost and large-scale manufacturing and they are relatively
easy to associate with nucleic acids.
The addition of amino acids to liposome formulations was
previously tested as a method to improve drug delivery to
several tissues. For example, addition of asparagine and aspartic
acid improves skin permeation of several liposome formulations
(Park et al., 2013). Specifically in lung tissue, association of
liposomes with L-leucine was tested to deliver indomethacin,
and it was found that this amino acid contributed positively to
the characteristics of the powders (Chen et al., 2012). Moreover,
cationic lipids, and lysine were used to enhance delivery of
functional proteins into human cervical cancer cells, in the
presence of serum (Sarker et al., 2014).
Our group previously tested the impact of intratracheal
instillation of polymerized liposome formulations containing
cationic lipids (Xisto et al., 2012). Those results showed that
the formulations could induce inflammation and affected the
survival of treated animals. In this work, we intended to
characterize and test the safety and efficacy of polymerized
liposomes carrying different amino acids (L-cysteine, L-arginine,
or L-tryptophan) as a delivery system to the lungs.
METHODS
Liposome and Polymer Preparation
Lipids were purchased from Avanti Polar Lipids (Alabaster,
AL) and used without further purification. All solvents were of
analytical grade or higher.
Lipopolymers with or without amino acids were obtained
according to Figure 1. Briefly, lipids (6.4 µmol, 5.2mg) were
dissolved in chloroform; the solvent was flash-evaporated and left
under vacuum for 30 min. Large multilamellar vesicles (LMVs)
were obtained by adding 2ml of phosphate-buffered saline
(PBS, pH 7.4) with or without L-tryptophan, L-arginine and L-
cysteine. UV irradiation was accomplished with a Stratalinker
1800 (Stratagene, La Jolla, CA) to cross-link and polymerize
the diacetylenic LMVs. Polymerization was performed as
previously described (Alonso-Romanowski and Chiaramoni,
2003; Chiaramoni et al., 2008, 2010; Temprana et al., 2010;
Gasparri et al., 2011). Polymerization cycle energy was 360,000
mJ/cm2; each cycle was 1650 s in duration (15 cycles in total),
at a wavelength of 254 nm. The temperature was kept at 4◦C
in between cycles. LMV concentration was 2 mg/ml. Visible
spectra were recorded on a Shimadzu 160-A double beam
spectrophotometer (Shimadzu, Kyoto, Japan) between 400 and
600 nm before and after polymerization and for non-polymerized
liposomes.
Amino Acid Incorporation
L-Tryptophan, L-arginine, and L-cysteine were dissolved in
PBS and incorporated in the dry lipid film. The amino
FIGURE 1 | Scheme for preparation of the lipopolymers. First, MLVs were
obtained by Bingham’s method (Zar and Ferkol, 2014) and then polymerized
as described previously (Griesenbach and Alton, 2009).
acid concentration was 50mol% relative to the total lipid
concentration.
In vitro Release of Amino Acids
The amino acid releasing profile of polymerized liposomes
was studied in PBS as previously described (Fernandez-Ruocco
et al., 2013). Non-encapsulated amino acid was separated
by centrifugation. Polymerized liposomes with 50mol% of
L-tryptophan, L-arginine, or L-cysteine were prepared as
described above and 0.2-ml aliquots were withdrawn at
different times. The lipid suspension was incubated for 24 h
at 37◦C under constant agitation. After each sample was
withdrawn, an aliquot of PBS was added to maintain the
original concentration gradient. L-Tryptophan was quantified
spectrophotometrically from the supernatant using a UV-
visible spectrophotometer (Nanodrop 1000; Thermo Scientific,
Wilmington, DE). Absorbance was measured at 280 nm.
L-Arginine and L-cysteine were quantified colorimetrically
with fluorescamine and 5,5′-dithiobis(2-nitrobenzoic acid),
respectively (Miedel et al., 1989; Toyo’oka, 2009).
The release percentage was determined by the following
equation:
TL(%) = [(TLt+ TLt− 1)× 100] /TT
where TLt is the concentration of amino acid released at
different times, TLt − 1 is the concentration of amino acid
released in the previous sample (this was added to avoid error
of the concentration gradient) and TT is the total amino
acid concentration added to polymerized liposomes. An aliquot
was withdrawn immediately after preparation and it was used
to calculate the % of encapsulation. Amount of amino acid
withdrawn at time t = 0 was taken as 100% of encapsulation.
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Percentages of encapsulation of the remnant aliquots were
relative to the initial percentage.
Surface Modifications
To determine the spectral characteristics of the
membrane/solution interface, the visible spectra of the
merocyanine 540 (MC540) probe was recorded between
400 and 600 nm at 10◦C to maintain the gel phase because this
is the structure needed for the polymerization reaction. The
MC540 probe is sensitive to the polar environment. In water, the
spectra show two maxima (a dimer at 500 nm and a monomer
at 530 nm). In a hydrophobic environment, the maximum is
shifted toward 530 nm (MC540 dimer) and 570 nm (MC540
monomer). The first two are the characteristic absorbance
maxima when the membrane is in the gel phase, whereas the
second two are the characteristic absorbance maxima when the
membrane is in the liquid crystalline state (Lelkes and Miller,
1980). The ratio of the absorbance at 570 nm with respect to
500 nm, called the hydrophobicity factor (HF) (Chiaramoni
et al., 2008), determines the degree of hydrophobic sites exposed
to the interface. The MC540 stock concentration was ∼1 mg/ml.
MC540, freshly prepared, was added in aliquots to give a final
concentration of 10−6 M. The lipid/probe ratio was kept at
(160:1). The sample was allowed to equilibrate for 2 min at
15◦C to keep the lipids in the gel phase, and then measured.
To avoid scattering, LMVs without MC540 were used as
reference. The lipid concentration was kept at 2mg/ml for the
polymerization process and 0.6mg/ml for the measurements
of the visible spectra. HF was measured in samples with 15
polymerization cycles. The temperature was kept at 15◦C during
the measurements to ensure the gel phase.
FTIR Spectroscopy
Fourier-transform infrared (FTIR) spectroscopy was used to
study the interaction between lipopolymers and amino acids as
well as the changes induced by the polymerization process. To
this end, 0.4ml of the liposomal suspension with or without
amino acids or polymerization was lyophilized. The solid was
then resuspended in D2O in order to avoid interference induced
by H2O. The lipid suspension was pipetted onto ATR cells and
dried with a hair drier. Infrared spectra were recorded from 3000
to 1000 cm−1 in an IRAffinity-1 FTIR spectrometer (Shimadzu).
Data were analyzed, normalized, and baseline corrected with the
IRsolution software (Shimadzu). Frequencies were determined
by the peak identification routine of the software.
Animal Preparation and Experimental
Protocol
This study was approved by the Ethics Committee of the
Institute of Biophysics Carlos Chagas Filho, Health Sciences
Centre, Federal University of Rio de Janeiro. All animals received
humane care in compliance with the Principles of Laboratory
Animal Care formulated by the National Society for Medical
Research and the Guide for the Care and Use of Laboratory
Animals prepared by the National Academy of Sciences, USA.
Forty female BALB/c mice (20–25 g) were randomly assigned
to five groups (n= 8/group). In the control group (CTRL), 50 µl
of PBS was instilled intratracheally. In the lipopolymer groups,
animals were instilled with lipopolymers without DNA (a 1:1
mixture of 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC)/1,2-bis-(tricosa-10,12-diynoyl)-sn-glycero-3-
phosphocholine (DC8,9PC), polymerized by 15 UV light
cycles) pure (LIPO group) or conjugated with 50mol% of L-
tryptophan (TRP group), L-arginine (ARG group), or L-cysteine
(CYS group) at a concentration of 2mg/ml in 50 µl of PBS.
Animals were anesthetized with Sevoflurane (1 MAC), kept
in dorsal recumbence, and then local anesthesia was performed
with lidocaine (2%, 1ml, Cristalia, Sao Paulo, SP, Brazil), a 1-cm-
long midline cervical incision was made to expose the trachea,
and either lipopolymers or vehicle was instilled intratracheally
with an intratracheal aerosolizer (IA-1C S/M–551 Model; Penn-
Century, Inc., Philadelphia, PA) attached to an FMJ-250 high-
pressure syringe (Penn-Century, Inc.). The cervical incision was
closed with 5.0 silk suture and the mice were returned to their
cage. The animals recovered rapidly after surgery.
Mechanical Parameters
Twenty-four hours after the intra-tracheal instillation, animals
were sedated (diazepam 1mg intraperitoneally (ip), anesthetized
(thiopental sodium 20mg/kg ip), tracheotomized, paralyzed
(vecuronium bromide, 0.005mg/kg intravenously), and
ventilated with a constant flow ventilator (Samay VR15;
Universidad de la República, Montevideo, Uruguay) with the
following parameters: frequency of 100 breaths/min, tidal
volume (VT) of 0.2ml, and fraction of inspired oxygen of 0.21.
The anterior chest wall was surgically removed and a positive
end-expiratory pressure of 2 cm H2O applied. Airflow and
tracheal pressure (Ptr) were measured (Burburan et al., 2007).
Lung mechanics were analyzed by the end-inflation occlusion
method (Bates et al., 1988). In an open chest preparation,
Ptr reflects transpulmonary pressure (PL). Briefly, after end-
inspiratory occlusion, there is an initial fast drop in PL (1P1)
from the preocclusion value down to an inflection point (Pi),
followed by low pressure decay (1P2), until a plateau is reached.
This plateau corresponds to the elastic recoil pressure of the
lung (Pel).1P1 selectively reflects the pressure used to overcome
the airway resistance. 1P2 reproduces the pressure spent by
stress relaxation, or viscoelastic properties of the lung, together
with a small contribution of pendelluft. Static lung elastance
(Est) was determined by dividing Pel by VT. Lung mechanics
measurements were performed 10 times per animal. All data were
analyzed using ANADAT data analysis software (RHT- InfoData,
Inc., Montreal, Quebec, Canada).
Lung Histology
A laparotomy was done immediately after the determination of
lungmechanics and heparin (1000 IU) was injected intravenously
into the vena cava. The trachea was clamped at end expiration,
and the abdominal aorta and vena cava were sectioned, yielding
a massive hemorrhage that quickly killed the animals. The left
lung was then removed, fixed in 3% buffered formaldehyde and
embedded in paraffin. Slices were cut (4-µm thick) and stained
with hematoxylin–eosin. Lung histology analysis was performed
with an integrating eyepiece with a coherent system consisting of
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a grid with 100 points and 50 lines (known length) coupled to a
conventional light microscope (Olympus BX51; Olympus Latin
Americas Inc., Brazil). The volume fraction of collapsed and
normal pulmonary areas and the number of mononuclear and
polymorphonuclear cells in pulmonary tissue was determined
using the point-counting technique across 10 random, non-
coincident microscopic fields (Hsia et al., 2010).
eGFP Gene Delivery
Twenty female BALB/c mice were also randomly assigned to
five other groups in which animals received 50 µl of eGFP
plasmid DNA (pEGFP-C1, Vector, GenBank accession number:
U55763) in PBS (CTRL) or lipopolymers conjugated with the
plasmid in PBS (LIPO, CYS, TRP, or AAG) intratracheally (as
described previously in animal preparation). Nine micrograms of
DNA were used per dose in a final concentration of 2 mg/ml of
liposomes (Xisto et al., 2012).
Twenty-four hours after delivery, the animals were euthanized
and the lungs were collected, frozen in liquid nitrogen, and stored
at –80◦C for molecular analysis.
qRT-PCR
Total RNA was extracted from the frozen tissues using
an SV Total RNA Isolation System kit (Promega, Madison,
WI) according to the manufacturer’s recommendations. The
concentration of RNA was measured by spectrophotometry
(Nanodrop ND-1000; Thermo Scientific). First-strand cDNA
was synthesized from total RNA using the GoTaq 2-Step
RT-qPCR system (Promega, Madison, WI). Relative mRNA
levels were measured with a SYBR green detection system
usingMastercycler ep realplex (Eppendorf, Hamburg, Germany).
All samples were measured in triplicate. The relative mRNA
level of the eGFP gene was calculated as a ratio to the
housekeeping gene (acidic ribosomal phosphoprotein P0; 36B4).
The following primer sequences were used: eGFP: forward,
5′-CAC ATG AAG CAG CAG GAC TT-3′; reverse, 5′-GGT
GCG CTC CTG GAC GTA-3′; 36B4-Rplp0: forward, 5′-
CAA CCC AGC TCT GGA GAA AC-3′; reverse, 5′- GTT
CTG AGC TGG CAC AGT GA-3′. Total RNA from eGFP
transgenic mice was used as a positive control and taken as
100%. All results were expressed as relative to the positive
control.
Statistical Analyses
Statistical analyses were run on Graphpad Prism 6.0 software
(Graphpad, USA). Kolmogorov-Smirnov test was used to
establish normality. One-way ANOVA followed by Dunnett’s
test (for comparison with lipopolymers without conjugation)
or Tukey’s test (for comparison among all groups) were used
to compare values between groups. Values were considered
significant when p< 0.05.
RESULTS
Degree of Polymerization
To study the influence of amino acids on polymer formation, we
recorded the spectra of samples with and without L-tryptophan,
FIGURE 2 | Absorbance at 480nm corresponding to six polymerized
units conjugated effectively (gray bars) and absorbance at 520nm
corresponding to nine polymerized units conjugated effectively (white
bars). LIPO, lipopolymer alone; ARG, TRP, CYS, lipopolymer containing
L-arginine, L-tryptophan, and L-cysteine, respectively. Data are presented as
mean ± SD of four independent experiments. *Significant differences respect
to lipopolymer without aminoacids (P < 0.05). **Significant differences with
respect to lipopolymer without aminoacids (P < 0.01).
L-arginine, or L-cysteine. Figure 2 depicts absorbance at 480 nm
(6 polymeric units) and 520 nm (9 polymeric units) of the
polymerized samples.
According to the data, the amino acid that is more efficient
in inducing polymerization is L-arginine. Some authors
have reported that the polar heads of the phospholipids can
stabilize the positive charge of L-arginine. The phosphate
groups establish electrostatic interaction and hydrogen
bond with the guanidinium group of the amino acid
(Tsogas et al., 2005). As a result, L-arginine is inserted
at the level of the polar heads, thereby increasing the
compression of adjacent lipid and increasing the probability
of a random encounter of the carbon chains during
polymerization.
L-Tryptophan can also induce a higher concentration of
polymeric units with respect to lipopolymer without amino acids.
However, the effect is not as strong as that induced by L-arginine.
It has been reported that L-tryptophan has a preference for
the lipid interface (Esbjörner et al., 2007), but the hydrophobic
character of the indole group could not induce efficient lipid
packing as in the case of L-arginine. L-Tryptophan is capable of
inducing closeness between carbon chains, but not as efficiently
compared with L-arginine.
L-Cysteine cannot induce better polymerization efficiency in
comparison with lipopolymer without amino acids. At neutral
pH, L-cysteine has no charge (Veronese and Morpurgo, 1999).
This could prevent its interaction with the lipid membrane, so
the amino acid has no effect on polymerization efficiency.
To gain insights into the polymerization process in
relation to liposome structure, particularly surface packing,
the MC540 probe was used and HF was determined. As
seen in Figure 3, both L-arginine and L-tryptophan can
induce a decrease in HF. However, L-cysteine did not.
The polymerization process itself also induces a decrease
in HF. Decrease in HF is related to surface packing; a
high HF means low membrane packing (Lelkes and Miller,
1980).
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FIGURE 3 | HF (Absorbance at 570nm/ Absorbance at 500nm) of the
lipopolymer (LIPO) or the lipopolymer with the different amino acids
(ARG, TRP, CYS). Data are presented as mean ± SD of four independent
experiments. *Significant differences respect to lipopolymer without
aminoacids (P < 0.05). **Significant differences with respect to lipopolymer
without aminoacids (P < 0.01).
FIGURE 4 | In vitro release of amino acids . Data are presented as means
± SD of three independent experiments. Amino acids tested were L-cysteine
(triangles), L-arginine (circles), and L-tryptophan (squares).
In vitro Release of Amino Acids
We determined the in vitro release of the three amino acids
(Figure 4). L-Cysteine is released more rapidly from the bilayer
than the other amino acids. It has an encapsulation efficiency
of 42 ± 5%. From data corresponding to the hydrophobicity
index and polymerization efficiency, we observed that this amino
acid does not induce better polymerization with respect to the
control and disorganizes the membrane surface. Thus, it can be
suggested that, due to a less rigid surface, the amino acid cannot
establish a strong interaction with the bilayer, and it is quickly
released.
L-Arginine is released relatively quickly. It has an
encapsulation efficiency of 45 ± 3%. The positive charge of
the amino acid and the rigidity induced in the membrane after
polymerization (as shown by the hydrophobicity index and
polymerization efficiency results) could be responsible for the
slightly more controlled release than that of L-cysteine.
L-Tryptophan has relatively low encapsulation efficiency
(17± 1%). However, it has a controlled release for nearly 12 h.
FTIR Spectroscopy
To analyze the position of the amino acid in contact with the
lipid groups, we recorded the FTIR spectra of polymerized and
non-polymerized liposomes to identify different interactions that
appeared to be due to the polymerization reaction.
The vibrational modes analyzed were reported by other
authors (Stanish and Singh, 2001; Fournier et al., 2008). The
terminal part of the head group of phosphocholine is the
choline group. The vibration that corresponds to the asymmetric
stretching of the +N(CH3)3 is at 960–980 cm
−1. The position
of this vibration has been shown to be sensitive to dipolar
interactions (Popova and Hincha, 2004). Table 1 shows the
results for the FTIR experiments. The polymerization process
diminishes polar interactions at the surface of the bilayer because
the position of the band in the case of polymerized formulations
is at higher frequencies. The addition of the three amino acids
diminishes these interactions. After the polymerization process,
L-arginine may induce a higher amount of dipolar interactions.
This is probably because, before the polymerization process, L-
arginine is mixed in the whole bilayer, but as polymerization
proceeds, domains are formed and phase separation appears.
L-Arginine then prefers a particular domain and increases dipolar
interactions at the surface of the bilayer.
In the case of L-tryptophan, the amino acid is mixed in
the whole bilayer and remains so after polymerization because
dipolar interactions do not change after the polymerization
process.
L-Cysteine interacts with the bilayer surface diminishing the
dipolar interactions even more, but shown by the encapsulation
efficiency, this interaction is weak.
The peak corresponding to the asymmetric stretching of
the P = O bond is between 1235 and 1250 cm−1. The
position of the peak is sensitive to the formation of H bonds
or coulombic interactions shifting to lower frequencies with
increasing bonding (Popova and Hincha, 2004). Table 1 presents
the results of these experiments. In the case of P = O vibrational
mode, the polymerization process diminishes its frequency,
suggesting the presence of more interaction at the P = O level.
These interactions decrease with the three amino acids before and
after polymerization and suggest that the part of the amino acid
that interacts with the P= O group is the same in each case.
Vibrations corresponding to the C = O group are between
1720 and 1750 cm−1 (Popova and Hincha, 2004). These
vibrations were analyzed but there were no differences between
the samples (data not shown).
Impact of Lipopolymers on Lung Function
and Inflammation
The survival rate at 24 h was 100% for all groups. Analysis of
lung resistive and viscoelastic pressures and static elastance at this
point showed no differences between the groups instilled with all
four types of lipopolymers and the control group (Figure 5).
The histologic properties of the lung were assessed to
evaluate lung inflammation (Figure 6C). First, we searched for
alterations in lung morphology, measuring the fractional area
of alveolar collapse (Figure 6A), and counting the number of
Frontiers in Physiology | www.frontiersin.org 5 April 2016 | Volume 7 | Article 151
Bandeira et al. Liposomes for Lung Gene Delivery
TABLE 1 | FTIR vibrational modes.
Vibrational
modes
Formulations
Lipopolymer Lipopolymer + L-arginine Lipopolymer + L-cysteine Lipopolymer + L-tryptophan
0
cycles
15
cycles
0
cycles
15
cycles
0
cycles
15
cycles
0
cycles
15
cycles
+N(CH3)3 968 972 970 968 970 974 970 970
P = O 1244 1238 1246 1244 1246 1244 1246 1244
FIGURE 5 | Effects of lipopolymers on lung function. Values are means ± SD of eight animals in each group (with 10 determinations per animal). Control group
(CTRL) was instilled with vehicle, LIPO group was instilled with the lipopolymer only, and the ARG, TRP, and CYS groups were instilled with the lipopolymer containing
L-arginine, L-tryptophan, and L-cysteine, respectively. (A) Lung static elastance (Est,L). (B) Stacked bar chart: the data in each gray bar represent the lung viscous
pressure (1P1) and the white bars are viscoelastic/inhomogeneous (1P2) pressure dissipation. The whole column represents the total pressure (1Ptot) variation in
each group.
inflammatory cells infiltrated in lung tissue (Figure 6B). No
significant differences were observed among the groups for both
parameters, suggesting a lack of inflammatory response triggered
by lipopolymer instillation.
Efficacy of eGFP Gene Delivery
In order to verify the efficacy of the eGFP gene delivery by
these lipopolymers when conjugated or not with amino acids,
we performed a quantitative RT-PCR assay on lung samples of
treated animals. We observed that there was accumulation of
mRNA for eGFP in all animals that received the lipopolymers
containing the eGFP plasmid. Conversely, the animals that
received only the free DNA plasmid did not show eGFP mRNA
levels. Furthermore, lipopolymers that did not contain amino
acids had a better efficacy in gene delivery than the arginine-,
cysteine-, and tryptophan-conjugated liposomes (Figure 7).
DISCUSSION
In this study, we developed lipopolymeric particles associated
with three different amino acids, and showed that amino acid
integration has different effects on polymerization, according
to the structure and net charge of the amino acid, but
does not halt the formation of lipopolymers. The amino
acids were selected based on their positive charge and better
DNA association (L-arginine), their hydrophobic characteristics
that have an influence on liposome stability (L-tryptophan;
Fernandez-Ruocco et al., 2013), and their ability to interact and
reduce the resistance of the mucus barriers (L-cysteine; Poelma
et al., 1990).
According to the data obtained in the efficiency
polymerization assay and HF determination (Figures 2, 3),
L-arginine induces the highest number of polymeric units as
a result of a combination of electrostatic and hydrophobic
interactions, because L-arginine induced the lowest HF
compared with the other amino acids. L-Tryptophan has only
a hydrophobic interaction and it can induce a decrease in HF,
but this decrease is lower than that observed for L-arginine.
L-Cysteine cannot establish efficient hydrophobic or electrostatic
interactions, so it has the lowest encapsulation efficiency and it
is released rapidly. Furthermore, we observed that L-tryptophan
could establish an ideal membrane surface rigidity providing
sustained release over time.
The difference in the concentration of the polymer units
generated by L-arginine could be explained by the differences
in net charge. In a study conducted by Wang et al. (2008), it
has been reported that the phase of a lipid bilayer composed
of phospholipids with phosphocholine heads can be modified
locally by a nanoparticle loaded with a specific charge.
Phosphocholine heads have an electric dipole choline phosphate
(P− N+). In the presence of charged particles, this dipole
changes its angle generating local phase changes. When the
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FIGURE 6 | Effects of lipopolymers on lung inflammation. The control group (CTRL) was instilled with vehicle, the LIPO group was instilled with the lipopolymer
only, and the ARG, TRP, and CYS groups were instilled with lipopolymer containing L-arginine, L-tryptophan, and L-cysteine, respectively. (A) Lung morphometry box
plot (min. to max.). (B) Lung cellularity (PMN, polymorphonuclear cells; MN, mononuclear cells). Values are means ± SD of five animals in each group (data gathered
from 10 random fields per animal). (C) Representative photomicrographs of lung parenchyma (×200, scale bar represents 100 µm). Asterisks indicate collapsed
alveoli.
FIGURE 7 | eGFP gene delivery on lung tissue. eGFP RNA levels
measured in the lungs of animals that received liposomes conjugated with a
DNA plasmid containing the eGFP gene (LIPO, ARG, TRP, and CYS groups),
or the free DNA plasmid in vehicle (CTRL). Values are given as percentage of
expression in relation to positive eGFP transgenic animals samples (mean ±
SD). *Significantly different from the CTRL, ARG, TRP, and CYS groups (P <
0.05).
nanoparticle has a net positive charge, such as in L-arginine, the
phosphocholine head tilts its usual angle of 30◦ to an angle of
∼65◦ characteristic of the gel phase, inducing an increased level
of packing. L-Tryptophan and L-cysteine have no net charges,
therefore, do not produce this effect on phosphocholine heads,
giving a smaller number of polymer units as a result.
Amino acids have been used extensively in biotechnology in
the production of pharmaceuticals due to their natural ability to
stabilize proteins and their adjuvant properties (Arakawa et al.,
2007); they are of great interest for their physiologic effects.
L-Cysteine is known to be important for response to oxidative
stress, because it is required for the synthesis of glutathione,
and exerts beneficial effects in oxidative stress in lung tissue
(Métayer et al., 2008; Mendoza et al., 2013). L-Arginine, a nitric
oxide precursor, has positive effects on respiratory illness, such as
post-cardiopulmonary bypass lung injury (Chao et al., 2011) and
asthma (Mabalirajan et al., 2010; Arıkan-Ayyıldız et al., 2014).
Besides its important role as a precursor of neurotransmitters,
L-tryptophan is metabolized by the enzyme indoleamine 2,3-
dioxygenase, produced by dendritic cells and macrophages, as
an immunosuppressive mechanism, which forms catabolites that
reduce T-cell proliferation and survival (Munn and Shafizadeh,
1999; Fallarino et al., 2002).
We noticed that no toxicity was observed in vitro using the
Caco-2 cell line and the MTT method [9,37] (data not shown),
and therefore we moved forward to test the toxicity of these
particles in vivo.
Using a dose of 2mg/ml, no morphologic or mechanical
changes were observed in the lungs of the animals and the
number of inflammatory cells in the lung tissue was not altered,
suggesting that these particles are safe for local delivery into the
lungs, independent of conjugation with or without amino acids.
Gene delivery is a major challenge in the treatment of
respiratory diseases, especially with regard to the development
of vectors. Most lung gene therapy trials have used viral
gene vectors, but these vectors have shortcomings, such as
inflammatory and immune responses of the host against the
viral particles acutely and on sensitization when multiple doses
are required, and limited plasmid size (Gautam et al., 2012).
Among non-viral vectors, cationic liposomes have been studied
extensively and are promising vectors for pulmonary gene
delivery (Simões et al., 2005; Cipolla et al., 2014). The size,
composition, and structure of the nanoparticles are essential
for their efficacy. Polymerized liposomes, composed of the
photopolymerizable lipid DC8,9PC) are more stable in different
media compared with the non-polymerized formulations, and
do not develop cell toxicity after polymerization (Alonso-
Romanowski and Chiaramoni, 2003; Yavlovich et al., 2009).
However, intravenous or local delivery of cationic liposomes
carrying DNA has led to inflammatory responses in several
instances (Freimark et al., 1998; Alton et al., 1999). Therefore,
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further development of less immunogenic, non-toxic liposome
carriers is of great interest.
We have found that polymerized liposomes composed of
DMPC/DP8,9PC, without conjugation with amino acids, were
efficient in causing gene expression in lung tissue, leading to
>30 times higher expression of the eGFP gene compared with
the delivery of naked DNA. Furthermore, this ability is impaired
after conjugation with the amino acids, suggesting that the DNA
interacts with the polar heads of the lipids, and this interaction is
halted by the presence of amino acids in these sites (Figure 7).
From these results, we can state that for the delivery and
expression of DNA to lung tissue, the best formulation is the one
developed with polymeric liposomes with no amino acids added,
because for this route of administration they added no benefits.
The sustained expression of the delivered gene remains to
be evaluated; here, we analyzed a single time point (24 h) after
transfection. In addition, further toxicity experiments are needed,
given that lipid/DNA complexes might present toxicity even
when the unconjugated liposomes do not cause significant harm
(Tousignant et al., 2000).
The characterization of the liposomes, taken together with
the efficacy in delivery of the eGFP gene to the lung tissue of
healthy mice, prompt us to suggest that these liposomes are an
interesting, stable alternative to be tested as gene delivery or drug
delivery carriers and adjuvants directly into the lungs.
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